NDC 68083-337 – Cytarabine
Cytarabine 100 mg/mL · Injection, Solution · Intrathecal, Intravenous, Subcutaneous
Product NDC68083-337
Product details
- Brand name
- Cytarabine
- Generic name
- Cytarabine
- Labeler
- Gland Pharma Limited
- Dosage form
- Injection, Solution
- Route
- Intrathecal, Intravenous, Subcutaneous
- Marketing category
- ANDA · ANDA211938
- Marketed since
- December 23, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Active ingredients
- Cytarabine 100 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 68083-337-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-337-01) / 20 mL in 1 VIAL, SINGLE-DOSE | Dec 23, 2019 |
Other Cytarabine products
- 63323-120 Cytarabine 100 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 68083-343 Cytarabine 20 mg/mL · Injection, Solution · Gland Pharma Limited
- 61703-155 Cytarabine 100 mg/mL · Injection, Solution · Hospira, Inc.
- 61703-303 Cytarabine 20 mg/mL · Injection, Solution · Hospira, Inc.
- 61703-304 Cytarabine 20 mg/mL · Injection, Solution · Hospira, Inc.
- 61703-305 Cytarabine 20 mg/mL · Injection, Solution · Hospira, Inc.
- 61703-319 Cytarabine 100 mg/mL · Injection, Solution · Hospira, Inc.
- 71288-108 Cytarabine 20 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-109 Cytarabine 2 g/20mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-168 Cytarabine 20 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-169 Cytarabine 20 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 25021-223 Cytarabine 100 mg/mL · Injection, Solution · Sagent Pharmaceuticals